Skip to main content
Article thumbnail
Location of Repository

New Concepts in Breast Cancer Emerge from Analyzing Clinical Data Using Numerical Algorithms

By Michael Retsky

Abstract

A small international group has recently challenged fundamental concepts in breast cancer. As a guiding principle in therapy, it has long been assumed that breast cancer growth is continuous. However, this group suggests tumor growth commonly includes extended periods of quasi-stable dormancy. Furthermore, surgery to remove the primary tumor often awakens distant dormant micrometastases. Accordingly, over half of all relapses in breast cancer are accelerated in this manner. This paper describes how a numerical algorithm was used to come to these conclusions. Based on these findings, a dormancy preservation therapy is proposed

Topics: Article
Publisher: Molecular Diversity Preservation International (MDPI)
OAI identifier: oai:pubmedcentral.nih.gov:2672332
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (1984). A computer simulation of breast cancer growth and treatment. In: American Association for Medical Systems and Informatics Proceedings
    2. (1988). A Gompertzian model of human breast cancer growth. Cancer Res.
    3. (1971). A high-resolution scanning electron microscope.
    4. (1993). A new paradigm for breast cancer.
    5. (1984). A stochastic numerical model of breast cancer growth that simulates clinical data. Cancer Res.
    6. (2001). Angiogenesis sustains tumor dormancy in patients with breast cancer treated with adjuvant chemotherapy. Breast Cancer Res. Treat
    7. (2000). Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drugresistant cancer. Cancer Res.
    8. (2009). Biological behavior of human breast cancer micrometastases.
    9. (2003). Breast cancer screening: controversies and future directions.
    10. (1997). Cancer dormancy: opportunities for new therapeutic approaches.
    11. (2004). Cancer without disease.
    12. (2004). Circulating tumor cells in patients with breast cancer dormancy. Clin. Cancer Res.
    13. (2007). Comparison of breast cancer mortality rates with those of ovarian and colorectal
    14. (1997). Computer simulation of a breast cancer metastasis model. Breast Cancer Res. Treat
    15. (2007). Confirmation of double-peaked time distribution of mortality among Asian breast cancer patients in a population-based study. Breast Cancer Res.
    16. (1973). Considerations of specimen damage for the transmission electron microscope, conventional versus scanning.
    17. (1988). Correspondence re: Larry Norton. A Gompertzian model of human breast cancer growth. Cancer Res.
    18. (2002). Dissemination and growth of cancer cells in metastatic sites.
    19. (2005). Does surgery induce angiogenesis in breast cancer? Indirect evidence from relapse pattern and mammography
    20. (2005). Does surgery unfavorably perturb the “natural history” of early breast cancer by accelerating the appearance of distant metastases?
    21. (2008). Dormancy and surgerydriven escape from dormancy help explain some clinical features of breast cancer. APMIS
    22. (1999). Dormancy of mammary carcinoma after mastectomy.
    23. (2005). Down's syndrome protects against breast cancer: is a constitutional cell microenvironment the key?
    24. (1969). Dynamics of growth in tumors and in normal organisms.
    25. (1964). Dynamics of tumor growth.
    26. (2006). Effects of estrogen receptor expression and histopathology on annual hazard rates of death from breast cancer. Breast Cancer Res. Treat
    27. Enhanced surgery-induced angiogenesis among premenopausal women may partially explain the breast cancer excess mortality of blacks compared to whites.
    28. (2000). Folkman’s War. Angiogenesis and the Struggle to Defeat Cancer.
    29. (1977). Growth kinetics of tumours: Cell Population Kinetics in Relation to the Growth and Treatment of Cancer;
    30. (1996). Haematogenous dissemination of prostate epithelial cells during surgery. Lancet
    31. (2005). Hazard rates of recurrence following diagnosis of primary breast cancer. Breast Cancer Res. Treat
    32. High serum endostatin levels in Down syndrome: implications for improved treatment and prevention of solid tumours.
    33. (2009). Hypothesis: induced angiogenesis after surgery in premenopausal node-positive breast cancer
    34. (2009). Hypothesis: primary antiangiogenic method proposed to treat early stage breast cancer.
    35. (2005). Improvements of breast cancer prediction in high risk intervals using artificial neural networks. Breast Cancer Res. Treat
    36. (2003). Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases. Breast Cancer Res. Treat
    37. (1990). Is Gompertzian kinetics a valid description of individual tumor growth?
    38. (2004). Karnofsky Memorial Lecture, Ignorato motu, ignoratur natura. ASCO 2004, American Society of Clinical Oncology Virtual Meeting,
    39. (1999). Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative
    40. (1994). Local recurrences following mastectomy: support for the concept of tumor dormancy.
    41. (2004). Menopausal status dependence of the timing of breast cancer recurrence following primary tumour surgical removal. Breast Cancer Res.
    42. (2001). Modeling tumor regrowth and immunotherapy.
    43. (1990). More evidence for circadian rhythm effects in cancer chemotherapy: the fluoropyrimidine story. Cancer Cells
    44. (2004). Non-linear survival analysis using neural networks.
    45. (1974). Observed single atom elastic cross sections in a scanning electron microscope. Optik
    46. (1972). One ampere current supply stable to one part per million per hour.
    47. (2002). Persistence of microscopic human cancers in mice: alterations in the angiogenic balance accompanies loss of tumor dormancy.
    48. (2002). Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy. Cancer Res.
    49. (1999). Perspective: tumour spread—the problems of latency.
    50. (2001). Premenopausal status accelerates relapse in node positive breast cancer: hypothesis links angiogenesis, screening controversy. Breast Cancer Res. Treat
    51. (1982). Principles of cancer biology: kinetics of cellular proliferation.
    52. (1991). Principles of medical oncology. In American Cancer Society Textbook of Clinical Oncology;
    53. (2003). Prolonged dormancy and site-specific growth potential of cancer cells spontaneously disseminated from nonmetastatic breast tumors as revealed by labeling with green fluorescent protein. Clin. Cancer Res.
    54. (1982). Prolonged survival in breast cancer. In Prolonged Arrest of Cancer.
    55. (1997). Proposal for a new model of breast cancer metastatic development.
    56. (1973). Quantitative and cytokinetic studies in experimental tumor models.
    57. (2004). Recent translational research in computational studies of breast cancer. Breast Cancer Res.
    58. (1991). Survival and age at diagnosis of breast cancer in a population-based cancer registry.
    59. (1991). The inhibition of tumor growth by tumor mass. Perspectives in cancer research. Cancer Res.
    60. (2007). The presence of Down syndrome is not a risk factor in complete atrioventricular septal defect repair.
    61. (2006). The problem of cancer dormancy: understanding the basic mechanisms and identifying therapeutic opportunities. Cell Cycle
    62. (1999). The shape of the hazard function in breast carcinoma. Cancer
    63. (2006). Trial Management Group. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years’ follow-up: a randomised controlled trial. Lancet
    64. (1999). Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment response and postvascular dormancy. Cancer Res.
    65. (2004). Universal law of tumor growth.
    66. (1996). Work on your theories.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.